Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules General Announcement Filing viewer · member access Original SGX announcement
Notice of 42nd Annual General Meeting of the Company General Announcement Filing viewer · member access Original SGX announcement
Intimation of the date of 42nd Annual General Meeting General Announcement Filing viewer · member access Original SGX announcement
Unaudited Financial Results for the First Quarter ended 30th June, 2020 General Announcement Filing viewer · member access Original SGX announcement
Glenmark introduces higher strength (400 mg) of FabiFlu General Announcement Filing viewer · member access Original SGX announcement
Credit Rating by Fitch Ratings General Announcement Filing viewer · member access Original SGX announcement
Outcome of the Board Meeting June 26, 2020 General Announcement Filing viewer · member access Original SGX announcement
GPL becomes the first company in India to receive regulatory approval for oral antiviral Favipiravir General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Fingolimod Capsules, 0.5 mg General Announcement Filing viewer · member access Original SGX announcement
Board Meeting Intimation for Audited Financial Results For the Quarter & Year Ended March 31, 2020 General Announcement Filing viewer · member access Original SGX announcement
GPL receives approval to conduct Trials in India on Favipiravir Antiviral for COVID19 patients General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets General Announcement Filing viewer · member access Original SGX announcement
GPL receives ANDA tentative approval for Dapagliflozin Tablets General Announcement Filing viewer · member access Original SGX announcement
Third Quarter Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals announces product approval for Ryaltris in Australia General Announcement Filing viewer · member access Original SGX announcement
Certificate of Compliance issued by the SUKL for GPL Baddi manufacturing facility General Announcement Filing viewer · member access Original SGX announcement
Outcome of the Board Meeting - November 14. 2019 General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Abiraterone Acetate Tablets USP, 250 mg General Announcement Filing viewer · member access Original SGX announcement
GPL receives tentative ANDA approval for Dimethyl Fumarate Delayed-Release Capsules General Announcement Filing viewer · member access Original SGX announcement
Update on the USFDA inspection of Glenmark Baddi manufacturing facility in Himachal Pradesh General Announcement Filing viewer · member access Original SGX announcement
Proceedings and Scrutinizer s Report of the 41st Annual General Meeting (AGM) General Announcement Filing viewer · member access Original SGX announcement
Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate General Announcement Filing viewer · member access Original SGX announcement
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam General Announcement Filing viewer · member access Original SGX announcement
Submission of Annual Report FY 2018-19 General Announcement Filing viewer · member access Original SGX announcement